Results 141 to 150 of about 5,903 (227)

Finding ferritin footprints in 5-fluorouracil-induced cardiotoxicity. [PDF]

Cardiooncology
Ferri GM, Urina-Jassir M, Stanisic AV, Hensien JM, Lee G, Sullivan N, Siddiqi OK.   +6 more
europepmc   +1 more source

Effective Management of Chemotherapy-Induced Cardiotoxicity: A Prospective Follow-Up Study on Alternative Regimens in Bangladeshi Cancer Patients. [PDF]

Cureus
Bhuiyan MZR, Hoque H, Alam S.
europepmc   +1 more source

Effective management of 5-fluorouracil-induced coronary vasospasm allowing chemotherapy continuation: a single-center observational study. [PDF]

Cardiooncology
Kolossváry K, Heltai K, Székely B, Rubovszky G.   +3 more
europepmc   +1 more source

Navigating Cardiotoxicity in Cancer Treatment: Insights into Fluoropyrimidine-induced Cardiac Events. [PDF]

Curr Cardiol Rev
Bhattarai A, Chakraborty M, Ali MHJ, Sharma C, Rai A, Acharya R, Rai Y, Bhattacharjee A, Bhuyan NR.   +8 more
europepmc   +1 more source

Stanford Type A Aortic Dissection During Adjuvant Capecitabine Chemotherapy for Colorectal Cancer. [PDF]

JACC Case Rep
Kawaguchi Y, Fukumoto Y, Aichi C, Konakano K, Tamaki M, Kitamura H, Okawa Y.   +6 more
europepmc   +1 more source

Severe acute myocarditis induced by 5-fluorouracil with successful rechallenge after multidisciplinary cardio-oncology evaluation: a case report. [PDF]

Eur Heart J Case Rep
Greco A, Pagani A, Modugno S, Iengo M, Rizzo G, Faverio C, Pedrazzoli P, De Luca L.   +7 more
europepmc   +1 more source

Dual Cardiotoxicity of Capecitabine: Coronary Vasospasm and QT Prolongation in a Patient With Gastric Adenocarcinoma. [PDF]

JACC Case Rep
Dominguez-Linares A, Nieto-Dolores AK, Ayala-Bustamante LE, Valencia Hernandez HA, Ruiz-Mori E, Gonzalez-Trejo A, Guerra EC, Acosta-Gutierrez GH, Ponce-Acosta C, Espinola-Zavaleta N.   +9 more
europepmc   +1 more source

The role of adjuvant chemotherapy in small bowel adenocarcinomas. [PDF]

Oncologist
Vora K, Moy RH, Neugut AI.
europepmc   +1 more source

Raltitrexed in Hepatocellular Carcinoma: Mechanistic Rationale and Clinical Evidence from Arterial-Based Therapies. [PDF]

J Hepatocell Carcinoma
Jia X, Ding Y, Chen Y, Wang W.
europepmc   +1 more source

UGT1A1 and irinotecan: Ready for routine pharmacogenetic care. [PDF]

Br J Clin Pharmacol
Swen JJ.
europepmc   +1 more source